To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(27 sites)

United States

University of California San Francisco Medical Center, San Francisco, California

Mayo Clinic Rochester, Rochester, Minnesota

Children'S Hospital of Philadelphia, Philadelphia, Pennsylvania

Penn Medicine - Perelman Center For Advanced Medicine, Philadelphia, Pennsylvania

Argentina

Hospital Italiano de Buenos Aires, Ciudad Autonoma Buenos Aires